Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kim, Hyung Ran ^a   Lee, Anbok ^a   Choi, Eun Jeong ^a   Hong, Min Pyo ^b   Kie, Jeong Hae ^c   Lim, Woosung ^a   Lee, Hyeon Kook ^a   Moon, Byung In ^a   Seoh, Ju Young ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b BOSTON COLLEGE   (United States)

^c National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIMETHOXY 1,4 NAPHTHOQUINONE; ACETYLCYSTEINE; IMIQUIMOD; INDOLEAMINE 2,3 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; 2,3-DIMETHOXY-1,4-NAPHTHOQUINONE; AMINOQUINOLINE DERIVATIVE; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; NAPHTHOQUINONE; NEUTROPHIL CYTOSOLIC FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HYPERKERATOSIS; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PARAKERATOSIS; PROTEIN EXPRESSION; PSORIASIS; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DEFICIENCY; DERMATITIS; DISEASE COURSE; DRUG EFFECTS; HYPERBARIC OXYGEN; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ACETYLCYSTEINE; AMINOQUINOLINES; ANIMALS; DERMATITIS; DISEASE PROGRESSION; GLUTATHIONE PEROXIDASE; HYPERBARIC OXYGENATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE, INBRED C57BL; NADPH OXIDASE; NAPHTHOQUINONES; PSORIASIS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, REGULATORY;

EID: 84897420138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091146     Document Type: Article

References (72)

1. Weigle N, McBane S (2013) Psoriasis. Am Fam Physician 87: 626-633.
2. Pouplard C, Brenaut E, Horreau C, Barnetche T, Misery L, et al. (2013) Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol 27 Suppl 3: 36-46.
3. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129: 79-88.
4. Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, et al. (2011) Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology 223: 57-67.
5. Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, et al. (2005) Dysfunctional blood and target tissue CD4 +CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174: 164-173. (Pubitemid 40007402)
6. Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, et al. (2011) Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 131: 1853-1860.
7. Chen AF, Chen DD, Daiber A, Faraci FM, Li H, et al. (2012) Free radical biology of the cardiovascular system. Clin Sci (Lond) 123: 73-91.
8. van Horssen J, Witte ME, Schreibelt G, de Vries HE (2011) Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta 1812: 141-150.
9. Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7: 567-573.
10. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646-12651. (Pubitemid 39122077)
11. Won HY, Jang EJ, Min HJ, Hwang ES (2011) Enhancement of Allergen-induced Airway Inflammation by NOX2 Deficiency. Immune Netw 11: 169-174.
12. Lee K, Won HY, Bae MA, Hong JH, Hwang ES (2011) Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci U S A 108: 9548-9553.
13. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, et al. (2008) Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 122: 1097-1103.
14. Won HY, Sohn JH, Min HJ, Lee K, Woo HA, et al. (2010) Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal 13: 575-587.
15. de Haan JB, Witting PK, Stefanovic N, Pete J, Daskalakis M, et al. (2006) Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J Lipid Res 47: 1157-1167. (Pubitemid 43830707)
16. Won HY, Jang EJ, Lee K, Oh S, Kim HK, et al. (2013) Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells. J Immunol 191: 4029-4037.
17. Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R (2009) The protective role of ROS in autoimmune disease. Trends Immunol 30: 201-208.
18. Efimova O, Szankasi P, Kelley TW (2011) Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One 6: e16013.
19. Vann RD, Butler FK, Mitchell SJ, Moon RE (2011) Decompression illness. Lancet 377: 153-164.
20. Guzman JA (2012) Carbon monoxide poisoning. Crit Care Clin 28: 537-548.
21. Korhonen K (2000) Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol 89 Suppl 214: 7-36.
22. Liu R, Li L, Yang M, Boden G, Yang G (2013) Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 88: 166-175.
23. Ozturk F, Ermertcan AT, Inanir I (2012) Hyperbaric oxygen therapy for the management of chronic wounds. Cutan Ocul Toxicol 32: 72-77.
24. Feldmeier JJ (2013) Hyperbaric oxygen therapy and delayed radiation injuries (soft tissue and bony necrosis): 2012 update. Undersea Hyperb Med 39: 1121-1139.
25. Hampson NB, Holm JR, Wreford-Brown CE, Feldmeier J (2011) Prospective assessment of outcomes in 411 patients treated with hyperbaric oxygen for chronic radiation tissue injury. Cancer 118: 3860-3868.
26. Allen S, Kilian C, Phelps J, Whelan HT (2012) The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Support Care Cancer 20: 2467-2472.
27. Olivieri AN, Mellos A, Duilio C, Di Meglio M, Mauro A, et al. (2010) Refractory vasculitic ulcer of the toe in an adolescent suffering from systemic lupus erythematosus treated successfully with hyperbaric oxygen therapy. Ital J Pediatr 36: 72.
28. Chen SY, Chen YC, Wang JK, Hsu HP, Ho PS, et al. (2003) Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB6NZW) F1 mice. Clin Immunol 108: 103-110.
29. Kudchodkar B, Jones H, Simecka J, Dory L (2008) Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipo-protein E knockout mice. Clin Immunol 128: 435-441.
30. Nagatomo F, Gu N, Fujino H, Okiura T, Morimatsu F, et al. (2010) Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collagen-induced arthritis. Clin Exp Med 10: 7-13.
31. Takeshima F, Makiyama K, Doi T (1999) Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer. Am J Gastroenterol 94: 3374-3375.
32. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J (2001) Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33: 337-339. (Pubitemid 32880978)
33. Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS (1998) Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 43: 512-518. (Pubitemid 28462037)
34. Olszanski R, Pachut M, Sicko Z, Sztaba-Kania M, Wilkowska A (1992) Efficacy of hyperbaric oxygenation in atopic dermatitis. Bull Inst Marit Trop Med Gdynia 43: 79-82.
35. Butler G, Michaels JC, Al-Waili N, Finkelstein M, Allen M, et al. (2009) Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature. J Med Case Rep 3: 7023.
36. Faleo G, Fotino C, Bocca N, Molano RD, Zahr-Akrawi E, et al. (2012) Prevention of autoimmune diabetes and induction of beta-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes 61: 1769-1778.
37. Thom SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 127 Suppl 1: 131S-141S.
38. Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985) 106: 988-995.
39. Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, et al. (2009) Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species. J Cell Biochem 108: 716-725.
40. Munn DH, Mellor AL (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 34: 137-143.
41. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
42. Thomas SR, Stocker R (1999) Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4: 199-220. (Pubitemid 30088218)
43. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36.
44. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, et al. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196: 447-457.
45. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845.
46. Jung YJ, Seoh JY (2009) Feedback loop of immune regulation by CD4+CD25+ Treg. Immunobiology 214: 291-302.
47. Kim HR, Kie JH, Lim W, Moon BI, Kim SC, et al. (2012) CD4(+)CD25(+) regulatory T cells from MRL/lpr mice were functionally more active in vitro but did not prevent spontaneous as well as adriamycin-induced nephropathy in vivo. Rheumatology (Oxford) 51: 1357-1367.
48. Novo E, Busletta C, Bonzo LV, Povero D, Paternostro C, et al. (2011) Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J Hepatol 54: 964-974.
49. Lin H, Liu XB, Yu JJ, Hua F, Hu ZW (2013) Antioxidant N-Acetylcysteine Attenuates Hepatocarcinogenesis by Inhibiting ROS/ER Stress in TLR2 Deficient Mouse. PLoS One 8: e74130.
50. Selman C, Blount JD, Nussey DH, Speakman JR (2012) Oxidative damage, ageing, and life-history evolution: where now? Trends Ecol Evol 27: 570-577.
51. Sohal RS, Orr WC (2011) The redox stress hypothesis of aging. Free Radic Biol Med 52: 539-555.
52. Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, et al. (1997) Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272: 16644-16651. (Pubitemid 27276497)
53. Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, et al. (2009) Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci 64: 1212-1220.
54. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, et al. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281: G848-855.
55. Kahles T, Brandes RP (2012) NADPH oxidases as therapeutic targets in ischemic stroke. Cell Mol Life Sci 69: 2345-2363.
56. Si CL, Shen T, Jiang YY, Wu L, Yu GJ, et al. (2013) Antioxidant properties and neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cells. Food Chem Toxicol 59: 145-152.
57. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, et al. (2010) Role of Treg in immune regulation of allergic diseases. Eur J Immunol 40: 1232-1240.
58. Ralainirina N, Poli A, Michel T, Poos L, Andres E, et al. (2007) Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 81: 144-153. (Pubitemid 46021263)
59. Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
60. Plafki C, Peters P, Almeling M, Welslau W, Busch R (2000) Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 71: 119-124. (Pubitemid 30070823)
61. Banham ND (2011) Oxygen toxicity seizures: 20 years' experience from a single hyperbaric unit. Diving Hyperb Med 41: 202-210.
62. Yildiz S, Aktas S, Cimsit M, Ay H, Togrol E (2004) Seizure incidence in 80,000 patient treatments with hyperbaric oxygen. Aviat Space Environ Med 75: 992-994. (Pubitemid 39435192)
63. Furuhashi T, Saito C, Torii K, Nishida E, Yamazaki S, et al. (2013) Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis. PLoS One 8: e54895.
64. Saito C, Maeda A, Morita A (2009) Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis. J Dermatol Sci 53: 231-233.
65. Soyland E, Heier I, Rodriguez-Gallego C, Mollnes TE, Johansen FE, et al. (2011) Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol 164: 344-355.
66. Briganti S, Wlaschek M, Hinrichs C, Bellei B, Flori E, et al. (2008) Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging. Free Radic Biol Med 45: 636-644.
67. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, et al. (2006) Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17: 58-60. (Pubitemid 44828801)
68. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, et al. (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185: 5953-5961.
69. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516-2522. (Pubitemid 21905800)
70. Narkowicz CK, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 19: 71-80. (Pubitemid 23310629)
71. Dennog C, Gedik C, Wood S, Speit G (1999) Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment. Mutat Res 431: 351-359. (Pubitemid 30017804)
72. Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis 11: 605-609. (Pubitemid 26397767)